Waldenstrom Macroglobulinemia Immunology
Scientists at Dana-Farber Cancer Institute publish research in waldenstrom macroglobulinemia immunology
Published in Hematology Week, October 15th, 2007
Research findings, 'Establishment of BCWM.1 cell line for Waldenström's macroglobulinemia with productive in vivo engraftment in SCID-hu mice,' are discussed in a new report. "A significant impairment in understanding the biology and advancing therapeutics for Waldenstrom's macroglobulinemia (WM) has been the lack of a representative cell line and animal model. We, therefore, report on the establishment of the BCWM.1 cell line, which was derived from the long-term culture of CD19(+) selected bone marrow lymphoplasmacytic cells isolated from an untreated patient with WM," researchers in the United States report.
"BCWM.1 cells morphologically resemble lymphoplasmacytic...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hematology Week
Source: Hematology Week (2007-10-15)
More Articles from Hematology Week
- Leukemia
Daisies lead scientists down path to new leukemia drug - Vascular Disease
UMass Medical School study identifies the best weight-loss plans for heart health - Biomedicine
New Transfusion Rules Restrict Donations from Previously Pregnant Women - Cord Blood
PerkinElmer to Expand Genetic Screening Business Through Acquisition of ViaCell - Cord Blood
StemCyte, Inc. Ranked Number Six in Deloitte's Technology Fast 50 Program for Los Angeles - Leukemia
Researchers Advancing Blood Cancer Therapies Receive $18.75 Million in Grants from the Society - More from this issue of Hematology Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
